RNAi Therapies and CRISPR Spark New Hope in HD Treatment
The global Huntington’s disease (HD) market is forecast to reach USD 1.9 billion by 2031, up from USD 961 million in 2023, growing at a compound annual growth rate (CAGR) of 9.1% during the forecast period. Fueled by increasing clinical trials, breakthroughs in RNA interference, and growing awareness, the HD market is poised for significant transformation. Huntington’s disease is a...
0 Comments 0 Shares 13 Views 0 Reviews